Internal Medicine, Medical Oncology · Detroit, MI
NPI
1902245269
Since 2013
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4100 John R St
Detroit, MI, 48201
Phone (313) 576-8722
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
272 services
Medicare patients, 2024
76
Average age 71
Drug cost, 2024
$683K
262 prescriptions
Company payments, 2025
$11K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dipesh Uprety was code 99214 (office e&m - established), 135 times for 39 patients. In total Dipesh Uprety billed 272 services in 10 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 135 | 39 | $74.88 | $10K |
| 99215 Office E&M - Established | Facility | 85 | 29 | $113.43 | $9,642 |
By year: 2022 $34K for 340 services; 2023 $29K for 314 services; 2024 $25K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dipesh Uprety prescribed most often to Medicare patients was Ondansetron Hcl, with 27 prescriptions and refills. In total Dipesh Uprety wrote 262 Medicare prescriptions that cost $683K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 27 | 27 | 16 | $144 |
| Prochlorperazine Maleate Generic | 24 | 24 | 17 | $290 |
| Krazati Adagrasib | 21 | 21 | Under 11 | $387K |
| Dexamethasone Generic | 20 | 20 | 11 | $306 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 18 | 18 | 12 | $210 |
| Potassium Chloride Generic | 17 | 17 | 11 | $88.89 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 14 | 14 | Under 11 | $389 |
| Prednisone Generic | 13 | 13 | Under 11 | $38.55 |
| Tagrisso Osimertinib Mesylate | 11 | 11 | Under 11 | $182K |
| Triamcinolone Acetonide Generic | 11 | 11 | Under 11 | $143 |
Brand drugs: 58 claims; generic drugs: 204 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dipesh Uprety $11K ($11K in general payments such as food, travel and fees) from 11 companies. The largest payer was Pfizer Inc. with $4,730.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.